NSUN2 promotes E2F1 expression in an m5C-dependent manner that is also dependent on YBX1 phase separation, and E2F1 can regulate NSUN2 transcription, thus forming the NSUN2-E2F1-NSUN2 feedback loop and providing a promising target for ovarian cancer therapy. This evidence concerns the gene E2F1 and ovarian cancer.